Bio-Rad Laboratories, Inc. Share Price
Stocks
BIO
US0905722072
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Cboe BZX
20:14:31 21/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 375.96 USD | -0.12% |
|
+1.96% | +24.02% |
| Market Cap | 10.01B 8.73B 8.22B 7.48B 14.03B 959B 14.05B 98.42B 37.93B 488B 37.59B 36.76B 1,576B | P/E 2026 * |
45.2x | P/E 2027 * | 44.2x |
|---|---|---|---|---|---|
| Enterprise Value | 9.26B 8.07B 7.6B 6.92B 12.98B 887B 13B 91.05B 35.09B 452B 34.78B 34.01B 1,458B | EV / Sales 2026 * |
3.6x | EV / Sales 2027 * | 3.43x |
| Free-Float |
60.17% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| BIO | Delayed | |
CBOE
| BIO | Real-time | |
|
Deutsche Boerse AG
| BUWA | Delayed | |
|
Tradegate
| BUWA | Real-time | |
|
Börse Stuttgart
| BUWA | Delayed | |
|
Boerse Muenchen
| BUWA | Real-time |
Last Transcript: Bio-Rad Laboratories, Inc.
| 1 day | -0.02% | ||
| 1 week | +1.96% | ||
| Current month | -2.68% | ||
| 1 month | -1.12% | ||
| 3 months | +33.67% | ||
| 6 months | +41.80% | ||
| Current year | +24.02% |
| 1 week | 366.28 |  | 385.71 |
| 1 month | 365.66 | | 396.23 |
| Current year | 236.73 | | 396.23 |
| 1 year | 236.73 | | 396.23 |
| 3 years | 211.43 | | 396.23 |
| 5 years | 211.43 | | 804.65 |
| 10 years | 154.89 | | 832.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Norman Schwartz
CEO | Chief Executive Officer | 76 | 31/12/2002 |
| President | 61 | 08/09/2024 | |
Roop Lakkaraju
DFI | Director of Finance/CFO | 55 | 14/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Norman Schwartz
CHM | Chairman | 76 | 31/12/2011 |
Jeffrey Edwards
BRD | Director/Board Member | 73 | 24/04/2017 |
Gregory Hinckley
BRD | Director/Board Member | 79 | 24/04/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 06/09/26 | Exercice | General Counsel | 1,841 | 0.0085% | ||
| 06/09/26 | Exercice | Chief Executive Officer | 8,764 | 0.0404% | ||
| 06/09/26 | Exercice | Chief Financial Officer | 3,854 | 0.0178% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.12% | +1.96% | +32.61% | +5.17% | 10.01B | |
| +0.50% | -0.26% | -24.74% | +3.93% | 178B | |
| +0.01% | -1.89% | -2.74% | +14.38% | 118B | |
| +2.33% | -3.04% | +9.53% | +71.04% | 58.92B | |
| -0.15% | -1.31% | -3.23% | -31.89% | 49.29B | |
| -0.22% | -0.37% | +10.27% | +42.75% | 48.17B | |
| +0.16% | +5.68% | +28.74% | +0.46% | 33.72B | |
| +0.32% | -2.82% | - | - | 27.76B | |
| -0.02% | +2.01% | +43.67% | -3.19% | 25.5B | |
| +1.77% | +9.57% | +9.06% | -13.10% | 22.1B | |
| Average | +0.49% | +1.68% | +11.46% | +9.95% | 57.09B | |
| Weighted average by Cap. | +0.49% | +0.97% | -2.23% | +12.45% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.57B 2.24B 2.11B 1.92B 3.61B 247B 3.61B 25.31B 9.75B 126B 9.67B 9.45B 405B | 2.63B 2.3B 2.16B 1.97B 3.69B 252B 3.7B 25.9B 9.98B 129B 9.89B 9.67B 415B |
| Net income | 225M 196M 185M 168M 315M 21.54B 316M 2.21B 852M 10.97B 845M 826M 35.41B | 230M 200M 189M 172M 322M 22.01B 322M 2.26B 871M 11.21B 863M 844M 36.18B |
| Net Debt | -749M -653M -615M -560M -1.05B -71.76B -1.05B -7.37B -2.84B -36.55B -2.81B -2.75B -118B | -965M -842M -793M -722M -1.35B -92.49B -1.36B -9.49B -3.66B -47.11B -3.63B -3.55B -152B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/09/26 | US$375.44 | -0.26% | 96,448 |
| 18/09/26 | US$376.41 | -1.57% | 324,347 |
| 17/09/26 | US$382.41 | +0.89% | 204,960 |
| 16/09/26 | US$379.03 | +0.27% | 262,414 |
| 15/09/26 | US$378.00 | +2.56% | 519,131 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIO Stock
Select your edition
All financial news and data tailored to specific country editions
